BALYASNY ASSET MANAGEMENT L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2023$4,659,968
-63.2%
54,733
-64.2%
0.01%
-68.8%
Q1 2023$12,657,606
-29.8%
152,962
-37.2%
0.03%
-41.8%
Q3 2022$18,039,000
-49.4%
243,677
-55.4%
0.06%
-52.6%
Q2 2022$35,632,000
+89.2%
546,676
+53.9%
0.12%
+81.2%
Q4 2021$18,836,000
-21.7%
355,127
+4.2%
0.06%
-36.0%
Q3 2021$24,058,000
+2873.8%
340,816
+2708.8%
0.10%
+2400.0%
Q2 2021$809,000
-95.9%
12,134
-92.6%
0.00%
-96.3%
Q4 2020$19,587,000
-14.3%
164,944
-37.0%
0.11%
-35.1%
Q3 2020$22,861,000
+101.9%
262,020
+107.3%
0.17%
+71.4%
Q2 2020$11,323,000
-43.7%
126,424
-27.8%
0.10%
-18.3%
Q4 2019$20,121,000
+2499.6%
175,119
+1879.6%
0.12%
+2300.0%
Q1 2019$774,000
+74.3%
8,846
+78.6%
0.01%
+150.0%
Q2 2018$444,000
+28.0%
4,953
-35.9%
0.00%
+100.0%
Q3 2017$347,000
-86.7%
7,730
-88.3%
0.00%
-90.9%
Q2 2017$2,618,00066,3000.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders